A detailed history of Fmr LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Fmr LLC holds 6,383,291 shares of FHTX stock, worth $53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,383,291
Previous 2,691,136 137.2%
Holding current value
$53 Million
Previous $18.1 Million 103.26%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.05 - $8.0 $18.6 Million - $29.5 Million
3,692,155 Added 137.2%
6,383,291 $36.7 Million
Q1 2024

May 13, 2024

SELL
$2.82 - $7.94 $335,221 - $943,851
-118,873 Reduced 4.23%
2,691,136 $18.1 Million
Q4 2023

Feb 13, 2024

SELL
$2.94 - $6.76 $259,337 - $596,299
-88,210 Reduced 3.04%
2,810,009 $18.1 Million
Q3 2023

Nov 13, 2023

SELL
$5.0 - $9.87 $47,530 - $93,824
-9,506 Reduced 0.33%
2,898,219 $14.5 Million
Q2 2023

Aug 11, 2023

SELL
$5.37 - $8.84 $576,131 - $948,417
-107,287 Reduced 3.56%
2,907,725 $20.5 Million
Q1 2023

May 11, 2023

SELL
$4.66 - $8.99 $477,100 - $920,414
-102,382 Reduced 3.28%
3,015,012 $18.7 Million
Q4 2022

Feb 13, 2023

SELL
$5.44 - $9.46 $1.63 Million - $2.83 Million
-298,938 Reduced 8.75%
3,117,394 $19.9 Million
Q3 2022

Nov 10, 2022

SELL
$7.52 - $18.01 $131,945 - $316,003
-17,546 Reduced 0.51%
3,416,332 $29.3 Million
Q2 2022

Aug 12, 2022

BUY
$8.48 - $16.84 $2.02 Million - $4.01 Million
238,012 Added 7.45%
3,433,878 $46.7 Million
Q1 2022

May 13, 2022

BUY
$8.87 - $22.1 $6.31 Million - $15.7 Million
711,032 Added 28.61%
3,195,866 $48.7 Million
Q4 2021

Feb 14, 2022

SELL
$10.79 - $22.87 $380,886 - $807,311
-35,300 Reduced 1.4%
2,484,834 $56.8 Million
Q3 2021

Nov 15, 2021

SELL
$8.33 - $15.02 $169,099 - $304,906
-20,300 Reduced 0.8%
2,520,134 $35.1 Million
Q2 2021

Aug 13, 2021

BUY
$9.32 - $13.26 $23.7 Million - $33.7 Million
2,540,434 New
2,540,434 $27.1 Million

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $346M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.